Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-24-010956
Filing Date
2024-08-06
Accepted
2024-08-06 08:00:33
Documents
91
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q hrmy-20240630x10q.htm   iXBRL 10-Q 1730921
2 EX-31.1 hrmy-20240630xex31d1.htm EX-31.1 16275
3 EX-31.2 hrmy-20240630xex31d2.htm EX-31.2 16876
4 EX-32.1 hrmy-20240630xex32d1.htm EX-32.1 9975
5 EX-32.2 hrmy-20240630xex32d2.htm EX-32.2 9501
  Complete submission text file 0001558370-24-010956.txt   8645793

Data Files

Seq Description Document Type Size
6 EX-101.SCH hrmy-20240630.xsd EX-101.SCH 67913
7 EX-101.CAL hrmy-20240630_cal.xml EX-101.CAL 80724
8 EX-101.DEF hrmy-20240630_def.xml EX-101.DEF 186344
9 EX-101.LAB hrmy-20240630_lab.xml EX-101.LAB 552031
10 EX-101.PRE hrmy-20240630_pre.xml EX-101.PRE 391795
94 EXTRACTED XBRL INSTANCE DOCUMENT hrmy-20240630x10q_htm.xml XML 1587212
Mailing Address 630 W GERMANTOWN PIKE SUITE 215 PLYMOUTH MEETING PA 19462
Business Address 630 W GERMANTOWN PIKE SUITE 215 PLYMOUTH MEETING PA 19462 (484) 539-9800
Harmony Biosciences Holdings, Inc. (Filer) CIK: 0001802665 (see all company filings)

EIN.: 822279923 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39450 | Film No.: 241177160
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)